A groundbreaking device designed to detect sexually transmitted infections (STIs) in asymptomatic women is nearing the final stage of clinical trials, with funding from the South African Medical Research Council (SAMRC).
The Genital Inflammation Test (GIFT) is a screening tool developed to identify STIs and Bacterial Vaginosis in women who may not exhibit symptoms. This innovative device aims to improve early detection and treatment by offering a more accessible and affordable option for women in resource-limited settings.
The study, part of a global collaboration, involves focus groups of nearly 700 women from South Africa, Zimbabwe, and Madagascar. One of the lead researchers, Professor Jo-Ann Passmore from the University of Cape Town, emphasized the importance of making the device widely available.
"Although accurate diagnostic tests exist for these conditions, they are often too expensive for widespread use in typical healthcare settings. The GIFT device, which works similarly to over-the-counter pregnancy tests, will provide a more affordable way to screen for inflammation biomarkers, allowing women to receive results during a single clinic visit," said Passmore.
The first results from the study are expected by December. The research team is currently working with the South African Health Regulatory Authority (SAHPRA) to submit their portfolios for approval, with hopes of making the device available in all reproductive health clinics soon.
This development holds the potential to significantly improve women's reproductive health by enabling early detection and treatment of infections that often go unnoticed.